DBL SODIUM NITROPRUSSIDE INJECTION 50MG/2ML

Product Information

Registration Status: Active

DBL SODIUM NITROPRUSSIDE INJECTION 50MG/2ML is approved to be sold in Singapore with effective from 1997-01-13. It is marketed by HOSPIRA SINGAPORE PTE LTD, with the registration number of SIN09146P.

This product contains Sodium Nitroprusside 25mg/ml in the form of INJECTION. It is approved for INTRAVENOUS use.

This product is manufactured by HOSPIRA INC HOSPIRA INC. in UNITED STATES.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Sodium Nitroprusside


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank